Analysis

Take-Two Interactive has closed its books on fiscal year 2026, with investor focus now squarely fixed on the horizon. The...

Biopharmaceutical firm Ocugen is transitioning from clinical development to the regulatory phase, with its lead gene therapy candidate approaching a...

In a rare admission, legendary investor Warren Buffett conceded to a significant error in judgment regarding his stake in Apple...

The independent Texas-based oil producer Battalion Oil is advancing a dual strategy to strengthen its financial foundation and sharpen its...

Salesforce is undertaking a significant overhaul of its Slack communications platform, aiming to position it as the central command center...

The advertising technology firm The Trade Desk is experiencing a significant shift in its shareholder base. Despite posting solid operational...

A strategic shift toward cultivating its developer community is providing a much-needed lift for IonQ's shares, following a sector-wide downturn...

All eyes are on Tilray Brands this Wednesday as the company prepares to release its third-quarter 2026 financial results. The...

After a period of significant market volatility, Teradyne is once again commanding attention from Wall Street analysts. The semiconductor equipment...

Market experts are growing more optimistic about Cardiff Oncology's financial trajectory. Following the biotechnology firm's stronger-than-anticipated performance in February, analysts...